Infection
The invasion of normally sterile tissue by organisms resulting in infectious pathology
Bacteraemia
Presence of viable bacteria in the blood
Sepsis
A life-threatening organ dysfunction caused by a dysregulated host response to infection (Sepsis-3 - 2016), as evidenced by organ dysfunction and infection.
Organ dysfunction = defined as an increase in 2 or more points in SOFA score - predicted mortality of 10% or more. NB SOFA score is an organ dysfunction score - not diagnostic of sepsis nor does it identify those whose organ dysfunction is truly due to infection but rather helps identify pts who potentially have a high risk of dying from infection.
Infection: no clear guidelines to help clinician identify the presence of infection or to causally link an identified organisms with sepsis.
So all sepsis has organ dysfunction by definition; SIRS as a term has fallen out of fashion and is no longer included in the definition of sepsis as it is not always caused by infection.
Septic shock
A subsect of sepsis in which underlying circulatory, cellular and metabolic abnormalities are profound enough to substantially increase mortality (is assoc w hosp mortality >40%).
Defined by patients who fulfill criteria for sepsis as above (have infection and increase in SOFA score of 2 or more) and also, despite adequate fluid resuscitation, require vasopressors to maintain a MAP of 65mmHg or more and have a lactate of over 2.
MODS
Multiple organ dysfunction syndrome = progressive organ dysfunction in an acutely ill pt, such that homeostasis can’t be maintained w/o intervention. Is at severe end of severity of illness spectrum of both infectious (sepsis, septic shock) and noninfectious conditions (eg SIRS from pancreatitis).
Can be classed as primary or secondary.
Primary = the result of a well-defined insult in which organ dysfunction occurs early & can be directly attributable to the insult itself (eg renal failure due to rhabdomyolysis)
Secondary = organ failure that’s not in direct response to the insult itself, but is a consequence of the host’s response (eg ARDS in pts w pancreatitis).
No universally accepted criteria for individual organ dysfunction in MODS, however the organ-specific parameters used in SOFA are commonly used to diagnose MODS.
In general, the greater the number of organ failures, the higher the mortality, w the greatest risk being associated w resp failure requiring mechanical ventilation.
SIRS
SIRS criteria is no longer used to identify those with sepsis since it is present in many hospitalised pts who don’t develop infection (e.g. autoimmune disorders, pancreatitis, vasculitis, thromboembolism, burns or surgery) & their ability to predict death is poor when compared w other scores e.g. SOFA score.
Is considered a clinical syndrome that is a form of dysregulated inflammation. Previously defined as 2 or more abnormalities in temp, HR, respiration or WCC.
qSOFA
Modified version of SOFA score. Identifies patients with suspected infection at risk of poor outcomes typical of sepsis (prolonged LOS, or in-hospital mortality) based on the presence of 2/3 of any of RR>22, SBP<100, altered mentation. Mortality risk of 10% in these patients in general hospital population. I.e. three components, each of which scores 1, and a score of 2 or more is associated with poor outcomes due to sepsis.
SOFA score
Sequential organ failure assessment score. Scores 6 organ systems from 0-4 - resp (PaO2, FiO2), coag (plts), liver (bili), cardio (hypotension, inotrope requirement), CNS (GCS), renal (creatinine). Score of 2 or more suggests presence of organ dysfunction. Dysfunction in 2 or more systems = MODS.
I.e. MODS is quantified by the SOFA score
Intra-abdominal hypertension & ACS
Normal intra-abdo pressure = 5-7mmHg
IAH = sustained or repeated pathological elevation in IAP ≥12mmHg
ACS = organ dysfunction caused by intra-abdominal hypertension (sustained IAP >20mmHg (w or w/o APP <60mmHg) that is assoc w new organ dysfunction/failure)
APP = MAP-IAP (target APP of ≥60mmHg is correlated w survival from IAH and ACS
Classification
IAH: grade 1 (12-15mmHg); grade 2 (16-20mmHg); grade 3 (21-25mmHg); grade 4 (>25mmHg)
ACS: primary or secondary
Classification of oeosphagitis
LA Classification
Grade A - one or more mucosal breaks, confined to mucosal folds, each not >5mm in max length
Grade B - one or more mucosal breaks >5mm in length, but not continuous between mucosal folds
Grade C - mucosal breaks that are continuous between the tops of 2 or more mucosal folds, but which involve <75% of the oesophageal circumference
Grade D - mucosal breaks which involve ≥75% of oesophageal circumference
Classification of gastric ulcers
Historically classified using the Johnson classification, which was anatomically based and related to acidic states:
UGI bleeding scores
How is acid reflux diagnosed and scored objectively
DeMeester score
Macroscopic appearance of gastric carcinoma - classification
Aberrant biliary anatomy
Aberrant hepatic arterial anatomy
Aberrant portal vein anatomy
Classification of bile duct injuries
Strasberg classification (modified from Bismuth)
A = bile leak from cystic duct stump or minor biliary radical in GB fossa
B = occlusion of part of biliary tree, usu aberrant RHD
C = transection but not occlusion of part of biliary tree, usu aberrant RHD
D = bile leak from main bile duct w/o major tissue loss (/lateral injury to biliary tree)
E1 = transection/stricture of main duct >2cm from confluence
E2 = transection/stricture of main duct <2cm from confluence
E3 = transection/stricture at confluence w R and L ducts in continuity
E4 = transection/stricture at confluence w separation of R and L ducts
E5 = combined injury to main duct and RPSD (involve aberrant RHD anatomy)
Classification of biliary SOD
Milwaukee (or Hogan-Geenan) classification
Classification of cholangiocarcinoma
Classification of choledochal cysts and their treatment
Todani classification
?Treat complications first. Then excise affected disease removing all cyst epithelium and therefore malignant potential. Cholecystectomy and REY hepatico-jejunostomy.
Complications: cholangitis, primary duct stones (both choledocholithiasis and cystolithiasis), hepatolithiasis, secondary biliary cirrhosis due to prolonged biliary obstruction & recurrent cholangitis, CA (10-30%), intraperitoneal cyst rupture, acute and chronic pancreatitis, bleeding due to erosion of cyst into adjacent vessels or as a result of portal hypertension, often presenting as GI haemorrhage due to haemobilia, GOO from obstruction of duo lumen
Pathogenesis of malignancy = field change - entire biliary tree at risk, even nondilated portions & complete excision of a benign choledochal cyst doesn’t eliminate risk of subsequent cholangiocarcinoma development
Mirizzi classification
Mirizzi syndrome = CHD obstruction caused by a gallbladder impacted in cystic duct or Hartmann’s pouch
type I (11%) = no fistula (type IA = cystic duct present; type IB = cystic duct obliterated)
type II (41%) = fistula involving <1/3 CBD width
type III (44%) = fistula involving 1/3-2/3 CBD width
type IV (1%) = fistula involving >2/3 CBD width / destruction of wall of CBD